<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XI-IATI-WBTF-P161232</iati-identifier>
  <reporting-org ref="XI-IATI-WBTF" type="40">
   <narrative xml:lang="EN">World Bank Trust Funds</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Support to Research and Development at the International AIDS Vaccine Initiative</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">The Project Development Objective is to support the International AIDS Vaccine Initiative (IAVI) in the optimization and testing of one HIV vaccine candidate.</narrative>
  </description>
  <participating-org ref="TF513001" role="1" type="10">
   <narrative xml:lang="EN">Japan - Ministry of Finance</narrative>
  </participating-org>
  <participating-org ref="TF072627" role="4" type="40">
   <narrative xml:lang="EN">Support to International AIDS Vaccine Initiative (formerly known as the Support to IAVI-Sendai Vector) SDTF - Parallel to TF071457</narrative>
  </participating-org>
  <activity-status code="3"></activity-status>
  <activity-date iso-date="2016-08-22" type="1"></activity-date>
  <activity-date iso-date="2016-08-22" type="2"></activity-date>
  <activity-date iso-date="2019-03-30" type="3"></activity-date>
  <activity-date iso-date="2019-05-15" type="4"></activity-date>
  <contact-info type="2">
   <organisation>
    <narrative xml:lang="EN"></narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN"></narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Mr Robert Oelrichs</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Health Specialist</narrative>
   </job-title>
   <telephone>1202-458-7916</telephone>
   <email></email>
   <mailing-address>
    <narrative xml:lang="EN">1818 H St, NW, Washington DC - 22036</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="1"></activity-scope>
  <recipient-region percentage="100" vocabulary="1">
   <narrative xml:lang="EN"></narrative>
  </recipient-region>
  <sector code="121" percentage="100" vocabulary="2">
   <narrative xml:lang="EN">+![cdata[Health, General]]+</narrative>
  </sector>
  <collaboration-type code="2"></collaboration-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget type="1">
   <period-start iso-date="2016-08-22"></period-start>
   <period-end iso-date="2019-03-30"></period-end>
   <value currency="USD" value-date="2021-11-30">3593757</value>
  </budget>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-30"></transaction-date>
   <value currency="USD" value-date="2021-11-30">3593757</value>
   <description>
    <narrative xml:lang="EN">Disbursement(Total Recipient-Executed Trust Funds Disbursements )-as of June 30th, 2020</narrative>
   </description>
   <provider-org provider-activity-id="XI-IATI-WBTF">
    <narrative xml:lang="EN">World Bank Trust Funds</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XI-IATI-WBTF-P161232">
    <narrative xml:lang="EN"></narrative>
   </receiver-org>
   <finance-type code="110"></finance-type>
  </transaction>
  <transaction>
   <transaction-type code="11"></transaction-type>
   <transaction-date iso-date="2020-06-30"></transaction-date>
   <value currency="USD" value-date="2021-11-30">3593757</value>
   <description>
    <narrative xml:lang="EN">Incoming Commitment (Total Grant Allocated Amount)-as of June 30th, 2020</narrative>
   </description>
   <provider-org provider-activity-id="XI-IATI-WBTF-TF072627">
    <narrative xml:lang="EN">Support to International AIDS Vaccine Initiative (formerly known as the Support to IAVI-Sendai Vector) SDTF - Parallel to TF071457</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="P161232">
    <narrative xml:lang="EN">Bilateral, unspecified</narrative>
   </receiver-org>
   <finance-type code="110"></finance-type>
  </transaction>
  <document-link format="APPLICATION/PDF" url="http://documents.worldbank.org/curated/en/503011471880980850/pdf/PIDC85416.pdf">
   <title xml:lang="EN">
    <narrative xml:lang="EN">Project Information Document</narrative>
   </title>
   <category code="A02"></category>
   <category code="A03"></category>
   <category code="A05"></category>
  </document-link>
  <document-link format="APPLICATION/PDF" url="http://documents.worldbank.org/curated/en/507651521130085508/pdf/ITKWB532331-201802151205.pdf">
   <title xml:lang="EN">
    <narrative xml:lang="EN">Agreement</narrative>
   </title>
   <category code="A02"></category>
   <category code="A04"></category>
   <category code="A05"></category>
   <category code="A06"></category>
   <category code="A09"></category>
  </document-link>
  <document-link format="APPLICATION/PDF" url="http://documents.worldbank.org/curated/en/232321488829527997/pdf/ITK171540-201702061443.pdf">
   <title xml:lang="EN">
    <narrative xml:lang="EN">Grant or Trust Fund Agreement</narrative>
   </title>
   <category code="A02"></category>
   <category code="A04"></category>
   <category code="A05"></category>
   <category code="A06"></category>
   <category code="A09"></category>
  </document-link>
  <document-link format="APPLICATION/PDF" url="http://documents.worldbank.org/curated/en/262661555033311333/pdf/Implementation-Completion-and-Results-Report-ICR-Document-Support-to-Research-and-Development-at-the-International-AIDS-Vaccine-Initiative-P161232.pdf">
   <title xml:lang="EN">
    <narrative xml:lang="EN">Implementation Completion and Results Report</narrative>
   </title>
   <category code="A07"></category>
   <category code="A08"></category>
  </document-link>
  <document-link format="APPLICATION/PDF" url="http://documents.worldbank.org/curated/en/174791510768275361/pdf/Disclosable-Version-of-the-ISR-Support-to-Research-and-Development-at-the-International-AIDS-Vaccine-Initiative-P161232-Sequence-No-02.pdf">
   <title xml:lang="EN">
    <narrative xml:lang="EN">Implementation Status and Results Report</narrative>
   </title>
   <category code="A07"></category>
   <category code="A08"></category>
  </document-link>
  <document-link format="APPLICATION/PDF" url="http://documents.worldbank.org/curated/en/601791537987281610/pdf/Disclosable-Version-of-the-ISR-Support-to-Research-and-Development-at-the-International-AIDS-Vaccine-Initiative-P161232-Sequence-No-03.pdf">
   <title xml:lang="EN">
    <narrative xml:lang="EN">Implementation Status and Results Report</narrative>
   </title>
   <category code="A07"></category>
   <category code="A08"></category>
  </document-link>
  <document-link format="APPLICATION/PDF" url="http://documents.worldbank.org/curated/en/633201496188300766/pdf/ISR-Disclosable-P161232-05-30-2017-1496188292768.pdf">
   <title xml:lang="EN">
    <narrative xml:lang="EN">Implementation Status and Results Report</narrative>
   </title>
   <category code="A07"></category>
   <category code="A08"></category>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.worldbank.org/projects/P161232?lang=en">
   <title xml:lang="EN">
    <narrative xml:lang="EN">Project URL</narrative>
   </title>
   <category code="A12"></category>
  </document-link>
  <related-activity ref="XI-IATI-WBTF-TF072627" type="1"></related-activity>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">PDO Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Vector has been optimized</narrative>
    </title>
    <baseline iso-date="2016-07-04" value="No" year="2016">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2016-07-04"></period-start>
     <period-end iso-date="2017-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="Yes"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">PDO Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Vector testing has been initiated</narrative>
    </title>
    <baseline iso-date="2016-07-04" value="No" year="2016">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2016-07-04"></period-start>
     <period-end iso-date="2017-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="Yes"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A decision to test new VSVdG-Env.BG505 vaccines or revise a macaque study to evaluate the requirement for three doses have been made.</narrative>
    </title>
    <baseline iso-date="2017-02-10" value="No" year="2017">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2017-02-10"></period-start>
     <period-end iso-date="2017-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="Yes"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Candidate vaccines have been produced for a preclinical study.</narrative>
    </title>
    <baseline iso-date="2017-02-10" value="No" year="2017">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2017-02-10"></period-start>
     <period-end iso-date="2017-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="Yes"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Five genetically modified VSVdG-Env.BG505 vaccines have been isolated and characteristics have been analyzed</narrative>
    </title>
    <baseline iso-date="2017-02-10" value="No" year="2017">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2017-02-10"></period-start>
     <period-end iso-date="2017-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="Yes"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Preclinical study in non-human primates has been commenced.</narrative>
    </title>
    <baseline iso-date="2017-02-10" value="No" year="2017">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2017-02-10"></period-start>
     <period-end iso-date="2017-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="Yes"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">VSVdG-Env.BG505 mutants have been isolated after serial passage under conditions that select for viruses with increased replicativefitness. Mutant virus characteristics have been analyzed.</narrative>
    </title>
    <baseline iso-date="2017-02-10" value="No" year="2017">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2017-02-10"></period-start>
     <period-end iso-date="2017-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="Yes"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Conduct serial passage of VSV New Jersey vector to improve replicative capacity and fitness of the virus</narrative>
    </title>
    <baseline iso-date="2017-06-20" value="No" year="2017">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2017-06-20"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="No"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Determination of construction feasibility and replicative capacity of VSVdG-Env.BG505 with Env in position 2, 3 or 5</narrative>
    </title>
    <baseline iso-date="2017-06-20" value="No" year="2017">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2017-06-20"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="No"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evaluate VSV New Jersey vector for improved fitness and utility as a vaccine platform</narrative>
    </title>
    <baseline iso-date="2017-06-20" value="No" year="2017">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2017-06-20"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="No"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Feasibility of VERO-CD4/CCR5 cell line also expressing VSV glycoprotein G is demonstrated</narrative>
    </title>
    <baseline iso-date="2017-06-20" value="No" year="2017">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2017-06-20"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="No"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Initiate VSVdG-Env.BG505 position 1 vector vaccine rescue in Early Development Laboratory</narrative>
    </title>
    <baseline iso-date="2017-06-20" value="No" year="2017">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2017-06-20"></period-start>
     <period-end iso-date="2018-09-28"></period-end>
     <target value="No"></target>
     <actual value="No"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">VSVdG-Env.BG505 position 1 vector with Matrix protein (M) modifications that will dampen the innate immune response rescued</narrative>
    </title>
    <baseline iso-date="2017-06-20" value="No" year="2017">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2017-06-20"></period-start>
     <period-end iso-date="2018-09-28"></period-end>
     <target value="No"></target>
     <actual value="No"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">VSVdG-Env.BG505.1 vector with M modifications evaluated for genetic stability and replicative capacity</narrative>
    </title>
    <baseline iso-date="2017-06-20" value="No" year="2017">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2017-06-20"></period-start>
     <period-end iso-date="2018-09-28"></period-end>
     <target value="No"></target>
     <actual value="No"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">PDO Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Additional viral vectors have been developed</narrative>
    </title>
    <baseline iso-date="2017-09-06" value="No" year="2017">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2017-09-06"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="No"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Organize and facilitate meeting in conjunction with UHC Forum in December in Tokyo on Japanese investments in global health R&amp;D</narrative>
    </title>
    <baseline iso-date="2017-09-06" value="No" year="2017">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2017-09-06"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="No"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">PDO Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">VSVdG-Env.BG505.1 vaccine vector has been evaluated</narrative>
    </title>
    <baseline iso-date="2017-09-06" value="No" year="2017">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2017-09-06"></period-start>
     <period-end iso-date="2018-06-30"></period-end>
     <target value="Yes"></target>
     <actual value="No"></actual>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Intermediate Results Indicator</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Initiate VERO CD4/CCR5 VSV G expressing cell line in Early Development Laboratory</narrative>
    </title>
    <baseline iso-date="2017-09-06" value="No" year="2017">
     <comment>
      <narrative xml:lang="EN"></narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2017-09-06"></period-start>
     <period-end iso-date="2018-09-28"></period-end>
     <target value="No"></target>
     <actual value="No"></actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
